Pulmonary Arterial Hypertension
📧 Sign up to get email alerts when something new happens for Pulmonary Arterial Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: Examination of Ventavis (Iloprost) Inhalation Behavior Using the I-Neb AAD System in Patients With Pulmonary Arterial Hypertension When Switching the Iloprost Nebulizer Solution for Inhalation From 10 μg/mL (V10) to 20 μg/mL (V20)
A completed clinical trial examined Ventavis (iloprost) inhalation behavior using the I-Neb AAD system in patients with pulmonary arterial h…
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso® [Phase 2]
Phase 2 trial update evaluating UT-15C SR added to Tyvaso in patients with pulmonary arterial hypertension; study completed with posted resu…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: A Study of Ranolazine Acute Administration and Short Term Administration in Pulmonary Arterial Hypertension [Phase 1]
Phase 1 study update on ranolazine for pulmonary arterial hypertension reports completed results for acute and short-term administration.
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension
A clinical trial assessed the safety and efficacy of treprostinil to facilitate liver transplantation in patients with portopulmonary hypert…
-
CLINICAL_TRIALS trial_result · 2016-12-09Clinical Trial Update: Epoprostenol for Injection in Patients With Pulmonary Arterial Hypertension [Phase 3]
Phase 3 trial results for Epoprostenol for Injection in patients with pulmonary arterial hypertension have been posted. The study was sponso…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-11-17Clinical Trial Update: Study Of Right Ventricular Performance In PAH Patients Treated With Rapid Dose Treprostinil (Remodulin)
This clinical trial update reports on right ventricular performance in patients with pulmonary arterial hypertension treated with rapid-dose…
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: A Pharmacokinetic Substudy of the TDE-PH-304 Protocol [Phase 3]
A pharmacokinetic substudy embedded in a Phase 3 trial of TDE-PH-304 in pulmonary arterial hypertension has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2016-10-21Clinical Trial Update: To Compare the Pharmacokinetics of Traclear 62.5 mg Tablets and HGP1206 125mg 1 Tablet in Healthy Male Volunteers [Phase 1]
Phase 1 pharmacokinetic comparison of Traclear 62.5 mg tablets and HGP1206 125 mg in healthy male volunteers has been completed.
-
CLINICAL_TRIALS trial_result · 2016-10-05Clinical Trial Update: FK506 (Tacrolimus) in Pulmonary Arterial Hypertension [Phase 2]
Phase 2 trial results for tacrolimus (FK506) in pulmonary arterial hypertension have been completed and results posted.
-
CLINICAL_TRIALS trial_result · 2016-09-19Clinical Trial Update: Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl. [Phase 2]
Phase 2 study of inhaled GeNOsyl for pulmonary arterial hypertension and pulmonary hypertension due to idiopathic pulmonary fibrosis has com…
-
CLINICAL_TRIALS trial_result · 2016-08-31Clinical Trial Update: Feasibility of Slow-paced Respiration Therapy for Treatment of a Symptom Cluster in Pulmonary Arterial Hypertension [Phase 1, Phase 2]
A completed Phase 1/2 study evaluating the feasibility of slow-paced respiration therapy for managing symptoms in pulmonary arterial hyperte…
-
CLINICAL_TRIALS trial_result · 2016-08-31Clinical Trial Update: Contribution of Echocardiography to Prognostic Evaluation of Pulmonary Arterial Hypertension
A clinical trial investigating how echocardiography can improve prognostic evaluation in pulmonary arterial hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-30Clinical Trial Update: Single and Multiple Ascending Doses Clinical Pharmacology Study With KAR5585 [Phase 1]
Phase 1 study update reporting completion of single- and multiple-ascending-dose pharmacology evaluation of KAR5585 in pulmonary arterial hy…
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH) [Phase 1]
Phase 1 study evaluating dosing of sorafenib in patients with pulmonary arterial hypertension has been completed.
-
CLINICAL_TRIALS trial_result · 2016-08-15Clinical Trial Update: BREATHE 5-OL: Tracleer (Bosentan) in Patients With Pulmonary Arterial Hypertension Related to Eisenmenger Physiology [Phase 4]
Phase 4 clinical trial assessing bosentan (Tracleer) in patients with pulmonary arterial hypertension related to Eisenmenger physiology has …
-
CLINICAL_TRIALS trial_result · 2016-08-12Clinical Trial Update: Effect of Short-term Oxygen During CPET in Pulmonary Hypertension [Phase 2]
A Phase 2 trial evaluating the effect of short-term oxygen during CPET in pulmonary hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-09Clinical Trial Update: Anastrozole in Patients With Pulmonary Arterial Hypertension [Phase 2]
A Phase 2 trial evaluating anastrozole in patients with pulmonary arterial hypertension has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2016-06-08Clinical Trial Update: Pulmonary Hypertension in Interstitial Lung Disease
Clinical trial update indicating completion of a study on pulmonary hypertension in interstitial lung disease. The sponsor is Groupe d'Etude…
-
CLINICAL_TRIALS trial_result · 2016-05-16Clinical Trial Update: Remodulin® to Oral Treprostinil Transition [Phase 2]
Phase 2 trial results update evaluating transitioning patients with pulmonary arterial hypertension from Remodulin (treprostinil) to oral tr…
-
CLINICAL_TRIALS trial_result · 2016-05-06Clinical Trial Update: Iron Status and Hypoxic Pulmonary Vascular Responses [NA]
A clinical trial conducted by the University of Oxford on iron status and hypoxic pulmonary vascular responses has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-18Clinical Trial Update: Efficacy and Safety Study of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH) [Phase 2]
Phase 2 trial evaluating the efficacy and safety of udenafil in patients with pulmonary arterial hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-18Clinical Trial Update: Clinical Trial to Evaluate the Long-term Safety of Udenafil in Patient With PAH [Phase 2, Phase 3]
A phase 2/3 clinical trial evaluating the long-term safety of udenafil in patients with pulmonary arterial hypertension has completed. The s…
-
CLINICAL_TRIALS trial_result · 2016-03-21Clinical Trial Update: Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder
This clinical trial update notes termination of NCT00722254, a University of Utah study investigating reversible secondary myelofibrosis or …
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Early Detection of Pulmonary Arterial Hypertension Using Cardiac Magnetic Resonance Imaging
A Mayo Clinic clinical trial evaluating the use of cardiac magnetic resonance imaging for early detection of pulmonary arterial hypertension…
-
CLINICAL_TRIALS trial_result · 2016-03-01Clinical Trial Update: Selexipag (ACT-293987) in Pulmonary Arterial Hypertension [Phase 3]
A Phase 3 trial evaluating selexipag for pulmonary arterial hypertension has completed and results were posted in 2016.